Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Post Liver Transplant: early-phase trial registry
1 of 3 indexed Post Liver Transplant trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Post Liver Transplant: 3 US clinical trials tracked, 1 recruiting.
Post Liver Transplant is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Arpan A. Patel, MD, running 1 of these trials.
Enrollment posture brief
Registry condition post-liver-transplant
OPEN 1 | RECR 33% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Post Liver Transplant lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Post Liver Transplant on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Post Liver Transplant is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
CM for Patients With ALD After Liver Transplant
Arpan A. Patel, MD
NCT06304467
Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant
Albert Einstein Healthcare Network
NCT03386305
Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant
Gilead Sciences
NCT01687270
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Post Liver Transplant records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Post Liver Transplant trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Post Liver Transplant page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Post Liver Transplant trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Arpan A. Patel, MD sponsors the most Post Liver Transplant trials on record, review their full trial history before evaluating a specific study. See Arpan A. Patel, MD's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Post Liver Transplant condition card totals 3 registered trials; most-linked intervention Sofosbuvir; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.